COMMUNIQUÉS West-GlobeNewswire
-
DBV Technologies présente ses résultats financiers du premier semestre 2026 et fait le point sur ses activités le 16 julliet 2026
14/07/2026 -
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
14/07/2026 -
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
14/07/2026 -
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
14/07/2026 -
React19 Applauds Introduction of the Vaccine Injury Compensation Modernization Act of 2026
14/07/2026 -
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026 -
IBA – Information Réglementée
14/07/2026 -
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
14/07/2026 -
Arizona Nonprofit Launches "Ultimate Road Trip" Fundraiser Inspiring Families to Make Memories While Funding Childhood Blindness Research
14/07/2026 -
IBA – Regulated information
14/07/2026 -
TAP Sleep Care Highlights Breakthrough Case Study on myTAP® Oral Appliance in Journal of Dental Sleep Medicine: Dramatic Two-Night Improvement in Treatment-Resistant OSA
14/07/2026 -
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
14/07/2026 -
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
14/07/2026 -
Smile Doctors Outpaces First-Half Growth Plan, Nears 600 Locations Nationwide
14/07/2026 -
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access
14/07/2026 -
Dandy Unveils Polychromatic Shade™ to End the Trade-Off Between Dental Aesthetics and Affordability
14/07/2026 -
XOMA Royalty Announces Closing of Its Acquisition by Ligand
14/07/2026 -
Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China
14/07/2026 -
Visory Health Wins a Digital Health Award for Second Consecutive Year
14/07/2026
Pages